Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4139 Biotechnology

Not Yet Opened 05-21 16:00:00 EDT

71.27

+0.55

+0.77%

High71.51	Low70.03	Vol1.39B
Open70.72	D1 Closing70.72	Amplitude2.10%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O13.86B	T/O Rate--	Tradable Shares0.00
P/B6.746676	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"Biotechnology","latestPrice":71.26588,"timestamp":1779393599999,"preClose":70.71948,"halted":0,"volume":1387380696,"delay":0,"changeRate":0.007726,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":0.546394,"latestTime":"05-21 16:00:00 EDT","open":70.719215,"high":71.514885,"low":70.03054,"amount":13855721587.749561,"amplitude":0.020989,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1779456600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.746676,"peRate":-146.178186,"turnoverRate":0.042157,"increases":329,"decrements":173,"flats":10,"marketCap":1829516412556.25,"floatMarketCap":1636612804720.9727},"requestUrl":"/m/hq/s/BK4139/wiki","defaultTab":"wiki","newsList":[{"id":"2637960953","title":"AEON Financial Service Approves 20th Stock-Linked Compensation Plan for Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2637960953","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637960953?lang=en_us&edition=fundamental","pubTime":"2026-05-22 15:09","pubTimestamp":1779433756,"startTime":"0","endTime":"0","summary":"AEON Financial Service Co ( ($JP:8570) ) has shared an announcement. AEON Financial Service has approved the issuance of its 20th series of stock o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aeon-financial-service-approves-20th-stock-linked-compensation-plan-for-directors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aeon-financial-service-approves-20th-stock-linked-compensation-plan-for-directors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AEON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637395296","title":"Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan","url":"https://stock-news.laohu8.com/highlight/detail?id=2637395296","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637395296?lang=en_us&edition=fundamental","pubTime":"2026-05-22 14:45","pubTimestamp":1779432300,"startTime":"0","endTime":"0","summary":"Satellite symposium and exhibition engagement highlighted strong physician interest in MRD, MCED, and evidence-driven adoption of genomic testing.TAIPEI, May 22, 2026 /PRNewswire/ -- Gene Solutions, an innovative global biotechnology company advancing AI-powered multi-omics solutions for cancer detection and precision oncology, participated in the 30th Taiwan Joint Cancer Conference , marking its first major oncology conference presence in Taiwan.Scientific Program and Faculty HighlightsThe event brought together a distinguished faculty of Taiwan-based and regional experts to discuss the evolving role of liquid biopsy in precision oncology, with a focus on multi-omics, artificial intelligence, MRD, and MCED.Assistant Professor Aaron Tan Chia-Ken  delivered a pan-cancer perspective on the value of liquid biopsy and multi-omics across all stages of cancer care. He illustrated the broad clinical utility of liquid biopsy — from genotyping and treatment selection in advanced disease, ctDNA ","market":"nz","thumbnail":"https://mma.prnewswire.com/media/2985328/image1.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2985328/image1.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/gene-solutions-showcases-ai-powered-multi-omics-liquid-biopsy-innovations-at-tjcc-2026-advancing-precision-oncology-in-taiwan-302779916.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","MRD.AU","BK4179","BK4109","ARTY","BK7095","BK4528","BK4543","TAT","TAT.AU","BK7111","BK4139","NGS.AU","BK4121","BK4585","BK4551","AIPO","BK7078","NGS","BK4588","DNA.AU","AGIX","AI","DNA","AIYY","CHAT","BK4587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637395580","title":"Abivax SA  expected to post a loss of 84 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2637395580","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637395580?lang=en_us&edition=fundamental","pubTime":"2026-05-22 14:32","pubTimestamp":1779431541,"startTime":"0","endTime":"0","summary":"Abivax SA  expected to post a loss of84cents a share - Earnings Preview Abivax SA ABVX.OQ, ABVX.O is expected to  show a fall in quarterly revenue when it reports  results on May 25 for the period end","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nL8N41Z0C9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637393723","title":"Rift Helium Marks AIM Debut With Tanzania Push and Community Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2637393723","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637393723?lang=en_us&edition=fundamental","pubTime":"2026-05-22 14:11","pubTimestamp":1779430317,"startTime":"0","endTime":"0","summary":"Rift Helium plc ( ($GB:RIFT) ) just unveiled an update. Rift Helium plc, a newly listed AIM company focused on primary helium exploration in Tanzan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rift-helium-marks-aim-debut-with-tanzania-push-and-community-focus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rift-helium-marks-aim-debut-with-tanzania-push-and-community-focus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AIM","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637514393","title":"Immunovant’s Talent Crunch: How Human Capital Risks Could Derail IMVT-1402 Development Across Six Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2637514393","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637514393?lang=en_us&edition=fundamental","pubTime":"2026-05-22 14:00","pubTimestamp":1779429657,"startTime":"0","endTime":"0","summary":"Immunovant, Inc. (IMVT) has disclosed a new risk, in the Employment / Personnel category. Immunovant, Inc. faces a material human capital risk, as ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/immunovants-talent-crunch-how-human-capital-risks-could-derail-imvt-1402-development-across-six-indications?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/immunovants-talent-crunch-how-human-capital-risks-could-derail-imvt-1402-development-across-six-indications?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IMVT","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637360355","title":"Relay Therapeutics (RLAY) Is Up 6.9% After Zovegalisib Phase 2 Data And Equity Raise - Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2637360355","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637360355?lang=en_us&edition=fundamental","pubTime":"2026-05-22 11:37","pubTimestamp":1779421041,"startTime":"0","endTime":"0","summary":"Earlier in May 2026, Relay Therapeutics completed a US$275,000,004 follow-on equity offering at US$12 per share after releasing initial Phase 2 ReInspire data showing zovegalisib achieved a 60% volumetric response rate and broad symptom improvement in PIK3CA‑driven vascular anomalies with a safety profile supportive of chronic dosing.\nAn interesting angle is that zovegalisib is being advanced simultaneously in rare vascular anomalies and in an ongoing Phase 3 program for metastatic breast...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rlay/relay-therapeutics/news/relay-therapeutics-rlay-is-up-69-after-zovegalisib-phase-2-d","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rlay/relay-therapeutics/news/relay-therapeutics-rlay-is-up-69-after-zovegalisib-phase-2-d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4215","BK4139","EQR","BK4563","BK4588","RLAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637836082","title":"A Look At Generate Biomedicines (GENB) Valuation After Nvidia’s US$10.4 Million Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2637836082","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637836082?lang=en_us&edition=fundamental","pubTime":"2026-05-22 11:34","pubTimestamp":1779420874,"startTime":"0","endTime":"0","summary":"Nvidia’s recent US$10.4 million investment in Generate Biomedicines (GENB) has drawn fresh attention to the AI-focused biotech, as investors assess what this backing could mean for its drug development pipeline.\nSee our latest analysis for Generate Biomedicines.\nThe Nvidia investment comes after a volatile stretch for Generate Biomedicines, with a 1-day share price return of 7.37% to US$13.98, a 30-day share price return of 10.34% and a year to date share price return of 10.51%. This comes...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-genb/generate-biomedicines/news/a-look-at-generate-biomedicines-genb-valuation-after-nvidias","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-genb/generate-biomedicines/news/a-look-at-generate-biomedicines-genb-valuation-after-nvidias","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2272731782.SGD","LU0210536198.USD","BK4534","IE00BMPRXN33.USD","LU0056508442.USD","LU2097344357.USD","HK0000320264.USD","LU0672654240.SGD","IE00BFSS7M15.SGD","IE00BYXW3230.USD","LU2491049909.HKD","LU0203202063.USD","LU0942090050.USD","LU0823421416.USD","LU1496350502.SGD","LU1244550577.SGD","LU1861215975.USD","LU1633808545.USD","LU0868494617.USD","LU1720051108.HKD","LU0683600562.USD","SG9999015945.SGD","LU0353189680.USD","LU2077746001.SGD","LU1242518857.USD","LU0096364046.USD","LU0061474960.USD","LU2473716301.USD","3NVD.UK","LU2394011477.USD","IE0009G5SDU7.USD","LU1366192091.USD","SG9999002232.USD","LU0096362180.USD","BK4567","LU2125154778.USD","LU0345770308.USD","LU2954938101.SGD","NVDL","LU2458330243.SGD","LU2028103732.USD","LU2746668974.SGD","LU0708995401.HKD","BK4588","LU0211327993.USD","LU2360106780.USD","LU1400636657.SGD","SG9999014898.SGD","IE00BKPKM429.USD","LU0823434583.USD","BK4543","LU0511384066.AUD","NVDB","HK0000304805.HKD","LU1280957306.USD","LU1691799644.USD","NVDA","LU1037948541.HKD","LU0234572021.USD","LU2417539215.USD","LU2211815571.USD","SG9999014914.USD","BK4139","BK4585","LU1267930490.SGD","LU0127658192.USD","LU2360107168.USD","BK4608","LU0345769128.USD","LU2552382132.HKD","IE0034235303.USD","LU1035775433.USD","IE0004445015.USD","LU2249611893.SGD","LU0006306889.USD","LU2244417387.USD","NVDS.UK","IE00B5949003.HKD","LU1983260115.SGD","LU2322448791.USD","LU0472753341.HKD","LU1244550221.USD","LU2023251221.USD","IE0004445239.USD","LU1721428933.USD","SG9999015986.USD","LU0882574139.USD","IE00BK4W5L77.USD","LU1645745479.HKD","SG9999014906.USD","LU2092937148.SGD","LU0345769631.USD","LU2413666426.HKD","BK4550","SG9999018865.SGD","LU0094547139.USD","LU0174119429.USD","ANV","LU0640476718.USD","SG9999002224.SGD","HK0000819398.USD","LU0158827948.USD","LU1791710400.SGD","LU0979878070.USD","LU2505996509.AUD","LU0081259029.USD","LU1914381329.SGD","LU2471134952.CNY","LU2265009873.SGD","LU2756315318.SGD","IE0003U64NQ7.SGD","LU1323610961.USD","NVYY","LU2430703178.SGD","HK0000320223.HKD","LU1935042488.USD","LU2125909759.SGD","SGXZ81514606.USD","LU0256863811.USD","LU2896262040.SGD","LU0077335932.USD","LU1116320737.USD","LU0225283273.USD","LU0267386448.USD","LU0823414551.USD","NVD2.UK","LU1674673691.USD","LU2111349929.HKD","SG9999015358.SGD","LU0985320562.USD","LU0011850046.USD","NVD3.UK","LU1821325948.USD","SGXZ51526630.SGD","LU1670756490.USD","LU1804176565.USD","LU1551013342.USD","LU1145028129.USD","IE0005OL40V9.USD","LU0061475181.USD","LU0323591593.USD","LU2506951792.HKD","LU2100268510.USD","LU0689472784.USD","LU1718418525.SGD","LU1923622291.USD","LU2125909593.SGD","LU0211328371.USD","LU2089283258.USD","LU2264538146.SGD","SG9999014567.USD","LU1974910355.USD","LU1868837136.USD","LU0345770993.USD","LU0310799852.SGD","LU2083900584.USD","IE000ITXATA3.USD","LU2999663052.SGD","LU2168564495.EUR","LU1791710582.SGD","LU2462591277.SGD","SG9999017495.SGD","IE000YTNTUN2.SGD","SGXZ31699556.SGD","LU0048584097.USD","IE00BD6J9T35.USD","IE00B1BXHZ80.USD","LU0965509010.AUD","SGXZ99366536.SGD","LU1814569148.SGD","BK4529","LU0070217475.USD","LU2237957902.USD","LU1935042215.USD","BK4549","LU0106261372.USD","LU1861220033.SGD","NVDW","BK4532","IE0004091025.USD","LU2456880835.USD","BK4533","LU1934455194.USD","LU0158827781.USD","LU0234570918.USD","LU1548497426.USD","LU1989764748.USD","IE000W1ABFV2.USD","BK4581","LU2237957811.SGD","LU2125909247.SGD","LU1066051811.HKD","SG9999015341.SGD","SG9999015978.USD","LU0097036916.USD","LU0109391861.USD","BK4141","IE00BJLML261.HKD","IE00BK4W5M84.HKD","LU0057025933.USD","LU1316542783.SGD","IE00B775SV38.USD","LU2065171311.SGD","LU1935043536.SGD","LU2357305700.SGD","LU2272731600.USD","LU0029864427.USD","HK0000306701.USD","LU0210533765.USD","IE00B3S45H60.SGD","NVIW.SI","BK4592","LU2047632596.USD","LU0787776722.HKD","LU2491050154.USD","LU2023250504.SGD","LU1778281490.HKD","LU0642271901.SGD","LU2213496289.HKD","LU3102509885.SGD","LU0265550946.USD","LU1951200564.SGD","LU1496350171.SGD","LU0320765059.SGD","LU0957808578.USD","LU2637965513.SGD","LU2286300806.USD","LU1720051017.SGD","NVDX","LU1642822529.SGD","BK4598","LU0157215616.USD","LU0215105999.USD","LU0107464264.USD","LU1839511570.USD","LU2361045086.USD","LU2505996681.GBP","LU2065170008.USD","LU2420271590.USD","LU2168564222.USD","LU2063271972.USD","NVD","LU2271345857.HKD","LU0820561909.HKD","LU2168563687.JPY","LU0203201768.USD","IE00BMPRXR70.SGD","LU2403377893.USD","LU1934455863.HKD","BK4587","BK4605","LU2462591350.SGD","LU0353189763.USD","LU1064131342.USD","LU1429558221.USD","IE00BN29S564.USD","IE0034235295.USD","LU0210528500.USD","LU1066051498.USD","LU0345768153.USD","LU0128525929.USD","LU2294711713.HKD","IE00B19Z9505.USD","LU1699723380.USD","LU2471134879.HKD","LU0256863902.USD","LU1267930730.SGD","LU2552382058.USD","LU1989764664.SGD","IE00B775H168.HKD","LU0689626769.HKD","LU0964807845.USD","LU2592432038.USD","LU1127390331.HKD","LU0965508806.USD","LU1400636491.USD","IE00BZ1G4Q59.USD","LU1868836757.USD","IE0001KFT4U8.USD","IE00B3M56506.USD","LU1917777945.USD","BK4614","LU0175139822.USD","LU0345768740.USD","LU0289960550.SGD","SG9999015952.SGD","LU1629891620.HKD","HK0000914660.USD","LU2361044865.SGD","LU0823414478.USD","LU1935043023.USD","LU0868494708.USD","SG9999014880.SGD","LU0820562030.AUD","LU1861127337.USD","LU1712237335.SGD","LU0347712357.USD","LU1069344957.HKD","LU1934455277.USD","LU0957791311.USD","LU2191332357.HKD","LU2087621335.USD","LU0316494557.USD","LU2125909916.SGD","LU0072462426.USD","BK4503","LU0109392836.USD","LU0476273544.USD","LU0310800379.SGD","LU0788109477.HKD","LU1923622614.USD","IE00BMPRXQ63.HKD","LU0080751232.USD","LU2430703251.USD","IE00BQXX3D17.EUR","LU1815336760.USD","LU2242649171.HKD","LU2361044949.HKD","LU2746668461.USD","LU0444971666.USD","LU1868836914.USD","IE00BJJMRX11.SGD","IE00BQXX3C00.GBP","IE00B4YYXB79.USD","NVDD","LU0390134368.USD","LU1551013425.SGD","LU2242650005.HKD","LU0276348264.USD","LU2108987350.USD","LU2065171402.SGD","LU2087625088.SGD","LU0354030511.USD","LU2089284900.SGD","IE0009356076.USD","LU2237438978.USD","LU2471134523.USD","LU1244550494.USD","LU0719512351.SGD","LU1992135472.HKD","LU2756315664.SGD","LU0889565833.HKD","LU0708994859.HKD","LU2326559502.SGD","BK4554","LU0354030438.USD","LU0079474960.USD","LU1951198990.SGD","LU0786609619.USD","LU0274383776.USD","LU0820561818.USD","SG9999004303.SGD","LU2023250330.USD","IE00BJJMRY28.SGD","LU2054465674.USD","SNVD.UK","LU2089985449.USD","LU0061474705.USD","LU0133085943.USD","LU2860962120.EUR","LU2168564149.EUR","LU1992135399.USD","SG9999014575.USD","BK4612","LU1037948897.HKD","SG9999018857.SGD","LU2602419157.SGD","SG9999001424.SGD","LU0466842654.USD","IE00B19Z8W00.USD","LU2461242641.AUD","IE0004086264.USD","LU1267930573.SGD","LU2471134796.USD","LU0289961442.SGD","LU2092627202.USD","LU2272731865.HKD","NVDS","IE00BDRTCR15.USD","LU2452424414.USD","LU1232071149.USD","LU0265550359.USD","DIPS","LU1202635105.USD","LU0342679015.USD","SG9999014559.SGD","LU1923623000.USD","IE000KEQY171.SGD","LU1261432733.SGD","LU0143551892.USD","LU1242518931.SGD","NVII","LU1116320901.HKD","LU2433249047.HKD","LU2462157665.USD","LU0965509101.SGD","LU1989772923.USD","LU0154236417.USD","LU0238689110.USD","LU1066053197.SGD","LU0861579265.USD","GENB","LU2125154935.USD","BK4527","LU0289739343.SGD","LU0251132253.USD","LU0053666078.USD","IE0034235188.USD","LU1066051225.USD","LU1868836591.USD","LU1400636574.HKD","LU2065169927.USD","LU2491050071.SGD","IE00BKVL7J92.USD","LU1803068979.SGD","2NVD.UK","LU2463028550.USD","NVDO","LU0266013472.USD","LU0082616367.USD","LU2250418816.HKD","IE00B4JS1V06.HKD","IE00BKDWB100.SGD","LU2487616109.SGD","LU0528227936.USD","IE00BJTD4V19.USD","LU2381873111.SGD","IE00BWXC8680.SGD","LU0823421333.USD","IE00BJTD4N35.SGD","HK0000304797.USD","LU2413666699.HKD","LU1935042991.SGD","IE00BFSS8Q28.SGD","LU0187121727.USD","LU1366333091.USD","BK4551","LU2750360641.GBP","IE00BQXX3F31.USD","LU0308772762.SGD","LU0198837287.USD","LU2543165471.USD","LU0124676726.USD","LU2097344431.USD","IE00BZ199S13.USD","LU1868837300.USD","LU1084165304.USD","IE00BDCRKT87.USD","SG9999000418.SGD","LU0724617625.USD","LU1674673428.USD","LU0444973449.USD","LU1989772840.SGD","IE00B7KXQ091.USD","LU0557290698.USD","LU0943347566.SGD","07788","LU1623119135.USD","LU0965509283.SGD","07388","LU2357125470.USD","LU0494093205.USD","LU2458330169.SGD","LU2750360997.AUD","LU2247934214.USD","LU0417517546.SGD","LU0170899867.USD","LU2360032135.SGD","GB00BDT5M118.USD","IE00B1XK9C88.USD","LU1815333072.USD","LU0823434740.USD","LU2430703095.HKD","LU1119994496.HKD","LU2168564065.EUR","SGXZ23171101.USD","LU0069063385.USD","LU2236285917.USD","IE00B3SWFQ91.USD","NVDU","IE00BHPRN162.USD","LU0348723411.USD","IE00B19Z8X17.USD","LU1435385759.SGD","LU2106854487.HKD","LU1571399168.USD","HK0000532082.HKD","LU1153585028.USD","LU2290526834.HKD","HK0000914686.HKD","LU2931357623.SGD","NVDG","SG9999014542.SGD","BK4548","BK4579","LU1988902786.USD","LU2322448957.HKD","HK0000306685.HKD","LU2552382215.SGD","NVDQ","NVDY","LU1852331112.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637096361","title":"RenovoRx Insider Makes Bold Move With Fresh Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2637096361","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637096361?lang=en_us&edition=fundamental","pubTime":"2026-05-22 10:13","pubTimestamp":1779416013,"startTime":"0","endTime":"0","summary":"New insider activity at RenovoRx ( ($RNXT) ) has taken place on May 21, 2026. RenovoRx’s Chief Financial Officer, Mark Voll, has increased his stak...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/renovorx-insider-makes-bold-move-with-fresh-share-purchase-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/renovorx-insider-makes-bold-move-with-fresh-share-purchase-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RNXT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637361026","title":"Major Investor Quietly Ups Bet on Hemab Therapeutics in Fresh Stock Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2637361026","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637361026?lang=en_us&edition=fundamental","pubTime":"2026-05-22 10:12","pubTimestamp":1779415969,"startTime":"0","endTime":"0","summary":"New insider activity at Hemab Therapeutics Holdings, Inc. ( ($COAG) ) has taken place on May 21, 2026. Significant shareholder RA Capital Managemen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-ups-bet-on-hemab-therapeutics-in-fresh-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-ups-bet-on-hemab-therapeutics-in-fresh-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","COAG","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637361095","title":"Top Fate Therapeutics Insiders Quietly Unload Shares in Back‑to‑Back Moves","url":"https://stock-news.laohu8.com/highlight/detail?id=2637361095","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637361095?lang=en_us&edition=fundamental","pubTime":"2026-05-22 10:11","pubTimestamp":1779415906,"startTime":"0","endTime":"0","summary":"New insider activity at Fate Therapeutics ( ($FATE) ) has taken place on May 21, 2026. Key insiders at Fate Therapeutics have recently unloaded not...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-fate-therapeutics-insiders-quietly-unload-shares-in-back‑to‑back-moves-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-fate-therapeutics-insiders-quietly-unload-shares-in-back‑to‑back-moves-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FATE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637619366","title":"EQ Resources Seeks ASX Quotation for 5.4 Million New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2637619366","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637619366?lang=en_us&edition=fundamental","pubTime":"2026-05-22 09:00","pubTimestamp":1779411659,"startTime":"0","endTime":"0","summary":"The latest announcement is out from EQ Resources Limited ( ($AU:EQR) ). EQ Resources Limited has applied to the ASX for quotation of 5,401,667 new ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eq-resources-seeks-asx-quotation-for-5-4-million-new-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eq-resources-seeks-asx-quotation-for-5-4-million-new-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EQ","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637366695","title":"PYC Therapeutics outlines limits of data and risk profile in investor update","url":"https://stock-news.laohu8.com/highlight/detail?id=2637366695","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637366695?lang=en_us&edition=fundamental","pubTime":"2026-05-22 08:59","pubTimestamp":1779411570,"startTime":"0","endTime":"0","summary":"PYC Therapeutics Limited ( ($AU:PYC) ) has provided an update. PYC Therapeutics has released an investor presentation intended to update shareholde...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-outlines-limits-of-data-and-risk-profile-in-investor-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-outlines-limits-of-data-and-risk-profile-in-investor-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637365292","title":"Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX) and Cencora (COR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637365292","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637365292?lang=en_us&edition=fundamental","pubTime":"2026-05-22 08:40","pubTimestamp":1779410407,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Immuneering (IMRX) and Cencora (COR). Immuneering (IMRX) In a rep...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immuneering-imrx-and-cencora-cor-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immuneering-imrx-and-cencora-cor-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1430594728.SGD","LU1119994496.HKD","XBI","BK4175","LU0058720904.USD","LU2237957902.USD","LU2237957811.SGD","LU1084165304.USD","BK4588","LU1585245621.USD","LU0128526141.USD","BK4585","LU0029874061.USD","LU1814569148.SGD","XLV","LABU","BK4084","HCSG","BK4563","COR","SGXZ23171101.USD","IMRX","LU0289739699.SGD","LU1261432733.SGD","BK4139","BK4137","BK4581","BK4529","SG9999004303.SGD","BK4539","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637161365","title":"ContextLogic director Bobbili Raja buys $1.31 million common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2637161365","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637161365?lang=en_us&edition=fundamental","pubTime":"2026-05-22 08:38","pubTimestamp":1779410322,"startTime":"0","endTime":"0","summary":"ContextLogic Holdings’ director Bobbili Raja, a 10% owner, reported open-market purchases of 150,000 common shares through an estate planning vehicle.The shares were bought at weighted-average prices of USD 8.74, USD 8.77, USD 8.69.Holdings in the estate planning vehicle rose to 500,000 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ContextLogic Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 21, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL5fWs93:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ContextLogic director Bobbili Raja buys $1.31 million common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LOGC","BK4139","BK4220"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637365216","title":"Legend Biotech to Showcase New CAR-T Data at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2637365216","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637365216?lang=en_us&edition=fundamental","pubTime":"2026-05-22 08:36","pubTimestamp":1779410203,"startTime":"0","endTime":"0","summary":"Legend Biotech ( ($LEGN) ) has provided an announcement. On May 21, 2026, Legend Biotech announced that it will deliver multiple presentations at t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/legend-biotech-to-showcase-new-car-t-data-at-asco-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/legend-biotech-to-showcase-new-car-t-data-at-asco-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4022","BK4230","BK4581","CAR","BK4505","LEGN","BK4585","BK4139","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637365533","title":"Liminatus Pharma appeals Nasdaq delisting notice, trading suspension set May 29","url":"https://stock-news.laohu8.com/highlight/detail?id=2637365533","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637365533?lang=en_us&edition=fundamental","pubTime":"2026-05-22 08:28","pubTimestamp":1779409718,"startTime":"0","endTime":"0","summary":"Liminatus Pharma received a Nasdaq delisting notice on May 20, 2026, tied to failures to meet minimum market value thresholds for listed securities and publicly held shares.Trading in the common stock and warrants is set to be suspended at the open on May 29, 2026, unless an appeal is requested by May 27, 2026.An appeal request would pause the suspension and delisting process while the matter is reviewed by a Nasdaq hearings panel.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL1BPKNT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SG9999014005.SGD","BK4588","LU0314104364.USD","LU2210149790.SGD","BK4112","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU2095319765.USD","IE00B3QW5Z07.USD","SG9999014021.USD","SG9999014039.USD","IE00BN0W2V16.EUR","NDAQ","SG9999014013.SGD","LU2210150020.SGD","IE00BN0W2T93.GBP","BK4139","IE00BN0W2W23.USD","LIMN","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637365538","title":"Liminatus Pharma Announces Nasdaq Delisting Notification","url":"https://stock-news.laohu8.com/highlight/detail?id=2637365538","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637365538?lang=en_us&edition=fundamental","pubTime":"2026-05-22 08:28","pubTimestamp":1779409706,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nTUA9PFH7Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LIMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135998116","title":"Zai Lab Announces Leadership Change: President and COO to Step Down","url":"https://stock-news.laohu8.com/highlight/detail?id=1135998116","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135998116?lang=en_us&edition=fundamental","pubTime":"2026-05-22 08:28","pubTimestamp":1779409696,"startTime":"0","endTime":"0","summary":"Zai Lab Ltd (09688) has announced a change in its executive leadership. According to a filing, the company's board of directors has determined that Mr. Josh Smiley will no longer serve as President...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4585","BK4548","BK4588","LU2488822045.USD","BK1161","BK4526","ZLAB","09688","BK4139","BK1588","BK4531"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637363441","title":"Annovis Bio director Michael B Hoffman buys $141,027 of common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2637363441","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637363441?lang=en_us&edition=fundamental","pubTime":"2026-05-22 08:12","pubTimestamp":1779408722,"startTime":"0","endTime":"0","summary":"Annovis Bio director Michael B. Hoffman reported open-market purchases of 76,344 common shares at prices ranging from USD 1.75 to USD 1.9.An additional 223,357 shares were reported as held indirectly through the 2024 Hoffman Family Trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Annovis Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 21, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL39jCFH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Annovis Bio director Michael B Hoffman buys $141,027 of common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637365900","title":"Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2637365900","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637365900?lang=en_us&edition=fundamental","pubTime":"2026-05-22 08:00","pubTimestamp":1779408000,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md. and SUZHOU, China, May  21, 2026  (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company e","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/22/3299861/0/en/Ascentage-Pharma-Releases-Latest-Clinical-Data-from-Multiple-Trials-at-ASCO-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","PFS","BK4139","CR","PD","AAPG","BK4211","ORR","NB","BK4161","LU1169590202.USD","BK4168","LU1169589451.USD","BK4195","EWS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0073},{"period":"1month","weight":0.0549},{"period":"3month","weight":0.0773},{"period":"6month","weight":0.127},{"period":"1year","weight":0.2743},{"period":"ytd","weight":0.0892}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4139","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biotechnology,BK4139,Biotechnology股票,Biotechnology股票老虎,Biotechnology股票老虎国际,Biotechnology行情,Biotechnology股票行情,Biotechnology股价,Biotechnology股市,Biotechnology股票价格,Biotechnology股票交易,Biotechnology股票购买,Biotechnology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}